Peoria, Arizona · Care pathway
Get the product’s own harm information
Ask about the exact medicine and your own health history. Keep the answer tied to the product being discussed.
The label for your medicine versus another medicine’s label
Your medicine’s label
Ask what the label says, what applies to your situation, and who handles a problem.
Another medicine’s label
Labels checked September 17, 2026 show why the medicine name matters. The tesamorelin (EGRIFTA SV) label reports on the first 26 weeks of its trials. Reactions where the shot was given affected 25 of every 100 treated patients. The semaglutide (Ozempic) label reported these reactions in 2 of every 1,000 treated patients in its trials. These were different trials, so the figures do not directly compare the two medicines.NIH DailyMed · Tesamorelin label NIH DailyMed · Semaglutide label
Ask before a treatment decision
Known limits and urgent help
FDA (Food and Drug Administration) says a poorly made medicine can contain germs or other unwanted material, or the wrong amount of the part that does the medicine’s work, in material checked September 17, 2026.FDA · Problems making medicines to order
FDA does not review compounded (made-to-order) products before sale for their safety, quality, or results, as of September 26, 2026.FDA · Limits of review
MedlinePlus, checked September 17, 2026, says severe allergic reactions can threaten life and calls for emergency help for severe symptoms.NIH MedlinePlus · Severe allergic reactions
Symptoms of that reaction can include breathing trouble, trouble swallowing, or a swollen face or tongue.NIH MedlinePlus · Symptoms
Keep separate instructions for getting emergency help and for asking routine questions after the visit.
Keep this answer
Keep the medicine information and the ways to get urgent or routine help with the treatment plan.
Next pathwayMatch the delivery to the plan